CN103505539A - 一种治疗烫伤的中草药配方 - Google Patents
一种治疗烫伤的中草药配方 Download PDFInfo
- Publication number
- CN103505539A CN103505539A CN201310007445.8A CN201310007445A CN103505539A CN 103505539 A CN103505539 A CN 103505539A CN 201310007445 A CN201310007445 A CN 201310007445A CN 103505539 A CN103505539 A CN 103505539A
- Authority
- CN
- China
- Prior art keywords
- fructus
- herbal medicine
- chinese herbal
- scald
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000411851 herbal medicine Species 0.000 title claims abstract description 11
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 33
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 230000001338 necrotic effect Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 2
- 241001529821 Agastache Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 235000008078 Arctium minus Nutrition 0.000 abstract 1
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 244000000231 Sesamum indicum Species 0.000 abstract 1
- 235000003434 Sesamum indicum Nutrition 0.000 abstract 1
- 244000046101 Sophora japonica Species 0.000 abstract 1
- 235000010586 Sophora japonica Nutrition 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000020234 walnut Nutrition 0.000 abstract 1
- 230000009471 action Effects 0.000 description 17
- 230000000144 pharmacologic effect Effects 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000003610 charcoal Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 208000002474 Tinea Diseases 0.000 description 5
- 241000130764 Tinea Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000004856 capillary permeability Effects 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000027219 Deficiency disease Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 2
- 240000007711 Peperomia pellucida Species 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 229940118377 Vitamin antagonist Drugs 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 244000053095 fungal pathogen Species 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- GUMSHIGGVOJLBP-SLRPQMTOSA-N methyl hesperidin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 GUMSHIGGVOJLBP-SLRPQMTOSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000003998 snake venom Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 240000004510 Agastache rugosa Species 0.000 description 1
- 235000010686 Agastache rugosa Nutrition 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940031348 multivalent vaccine Drugs 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 125000000955 oleanolic acid group Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229940052228 zinc oxide paste Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种治疗烫伤的中草药配方，针对一般治疗烫伤的手段费用较高的缺点，提供的一种去腐生肌的中草药配方，其特征是：包括按照重量配比组成为：当归8~12g；藿香10~14g；木瓜8~12g；桃仁8~12g；菊花10~14g；陈皮8~12g；女贞子10~14g；芝麻10~14g；核桃仁10~14g；黄芩8~12g；山楂8~12g；荆芥10~14g；牛蒡子8~12g；续断8~12g；槐实10~14g；甘草7~11g；将按此重量配比组成的药物可制成煎熬液或粉碎成散剂或片剂。采用本配方不但治疗效果好，而且大大的节省病患的费用，减小了经济负担。
Description
技术领域
本发明是涉及医学领域，尤其是一种治疗烫伤的中草药配方。
背景技术
现今在治疗一些外伤烫伤严重的病人，其主要的治疗方法是植皮等手段，给病人造成了较大的痛苦。手术花费较高，给病人及家属带来沉重的心理和生理上的痛苦，对其以后的生活造成诸多不便。
发明内容
针对一般治疗烫伤的手段费用较高的缺点，本发明提供解决问题的技术方案是：包括按照重量配比组成为：当归8~12g；藿香10~14g；木瓜8~12g；桃仁8~12g；菊花10~14g；陈皮8~12g；女贞子10~14g；芝麻10~14g；核桃仁10~14g；黄芩8~12g；山楂8~12g；荆芥10~14g；牛蒡子8~12g；续断8~12g；槐实10~14g；甘草7~11g；将按此重量配比组成的药物可制成煎熬液或粉碎成散剂或片剂。
本发明提供的一种去腐生肌的中草药配方的最佳重量配比组成为：当归10g；藿香12g；木瓜10g；桃仁10g；菊花12g；陈皮10g；女贞子12g；芝麻12g；核桃仁12g；黄芩10g；山楂10g；荆芥12g；牛蒡子10g；续断10g；槐实12g；甘草9g。
本发明的有益效果是：不但治疗效果好，而且大大的节省病患的费用，减小了经济负担。
当归：抗缺氧、调节机体免疫功能、具有抗癌、护肤美容作用、补血活血、抑菌、抗动脉硬化。
药理作用：1）抑制血小板聚集作用。
2）当归有极显著的生血作用。
3）抗炎作用：降低毛细血管通透性；抑制PGE2的合成或释放。
4）抗菌作用：当归对体外痢疾、伤寒、副伤寒、大肠杆菌、白喉杆菌、霍乱弧菌及a、B溶血性链球菌等均有抗菌作用。该品可减少小鼠毛细血管通透性。外用能加速兔耳创面愈合，使局部充血、白细胞和纤维浸润，新生上皮再生，对局部组织有止血和加强末梢循环作用。说明当归有抗菌、消炎作用。当归热水提取物对慢性风湿性病实验动物模型在其佐剂关节炎急性发作时有明显的抑制作用。
藿香：祛暑解表；化湿和胃；手、足癣。
药理作用：1）抗真菌作用：藿香煎剂（8%～15%）在试管内对许兰毛癣菌等多种致病性真菌有抑制作用。
2）抗钩端螺旋体作用：藿香水煎剂在浓度为 15mg/ml 时对钩端螺旋体有抑制作用；当浓度增至 31mg/ml 时对钩端螺旋体有杀灭作用。
3）抗病毒作用：藿香中的黄酮类物质有抗病毒作用。
木瓜：除湿利痹，缓急舒筋。
药理作用：1）保肝作用。2）抗菌作用。
核桃仁：补肾温肺，润肠通便。
药理作用：1）补虚强体，提供营养：经动物实验证明，含胡桃油的混合脂肪饮食，可使体重增长，血清白蛋白增加，而血胆固醇水平升高却较慢，故核桃是难得的一种高脂肪性物质的补养品。
2）消炎杀菌，养护皮肤：核桃仁有直接的抑菌消炎作用。据临床报道，将核桃仁捣烂制成的核桃焦油氧化锌糊膏，治疗皮炎、湿疹，有效率可达100%。核桃仁富含的油脂，有利于润泽肌肤，保持人体活力。
3）防癌抗癌：实验证明，核桃有效成分对小鼠S37肿瘤有抑制作用。此外，核桃对癌症患者还有镇痛，提升白细胞及保护肝脏等作用。
4）净化血液，降低胆固醇：核桃仁能减少肠道对胆固醇的吸收。并可溶解胆固醇，排除血管壁内的“污垢杂质”使血液净化，从而为人体提供更好的新鲜血液。所以，核桃仁有防止动脉硬化，降低胆固醇的作用。此外，核桃还可用于治疗非胰岛素依赖型糖尿病。
菊花：疏风、清热、明目、解毒之功效。
药理作用： 抗炎作用早在1950 年，有研究者就发现菊花提取物能影响小鼠毛细血管的通透性，增加毛细血管抵抗力，从而具有抗炎作用。
陈皮：理气开胃 燥湿化痰 治脾胃病。
药理作用：抗炎、抗溃疡、利胆作用橙皮甙不能减轻大鼠后肢脚爪因甲醛引起的浮肿，柑橘属植物中顺式香豆素则有抗炎作用。甲基橙皮甙(以二氢黄酮型为主的混合物)对毛细管的通透性(家兔氯仿法及小白鼠蛇毒法)也有抑制作用，并能防止蛇毒引起的出血，毒性最低。甲基橙皮甙对结扎幽门引起的大白鼠溃疡，有明显的抗溃疡作用，与维生素C及K合用能增强其效力，口服则无效，给大白鼠腹腔注射，迅速表现利胆作用，维生素C及K亦可增强此作用。
牛蒡子：疏散风热；清热解毒透疹。
药理作用：1）抗菌抗病毒作用：牛蒡子水浸液（1：2)在试管内对茧色毛癣茵、同心性毛癣茵、许兰黄癣菌、奥杜盎小芽胞癣菌、羊毛样小芽胞癣茵、腹股沟表皮癣菌、红色表皮癣菌、星形奴卡菌、铁锈色小芽胞癣菌等9种致病性真菌有抑菌作用。有资料表明牛蒡子提取物具抗艾滋病病毒（HIV)活性。
2）牛蒡苷对蛙下肢及兔耳血管有扩张作用，短暂的降低血压，对离体兔子宫、肠管、运动神经及骨络肌均有抑制或麻痹作用。有轻度利尿、泻下作用。
女贞子：补益肝肾；清虚热。
药理作用：1） 对机体免疫功能的影响：升高外周白细胞数 女贞子能显著升高外周白细胞数目，其有效成分为齐墩果酸。醇提取物能回升环磷酰胺(cy）所致小鼠白细胞减少。
2）对细胞免疫功能的影响 女贞子能明显提高T淋巴细胞功能。
3）女贞子具有增强体液免疫功能的作用。
芝麻：伤中虚赢，补五内、益气力、长肌肉、填精益髓。
桃仁：活血祛瘀，润肠通便。
药理作用：桃仁提取液能明显增加脑血流量，增加犬股动脉的血流量，降低血管阻力，改善血流动力学状况。桃仁可使小鼠的出血及凝血时间明显延长，煎剂对体外血栓有抑制作用，水煎液有纤维促进作用。水煎剂及提取物有镇痛、抗炎、抗菌、抗过敏作用。
黄芩：清热燥湿，泻火解毒，止血，降血压。
药理作用：1）抗菌、抗病毒。
2）抗炎：黄芩素、黄芩苷可抑制急性炎症反应。抑制炎症模型渗出肿胀、毛细血管通透性增加；抑制大鼠佐剂性关节炎。
山楂：能消食积，补脾。
荆芥：祛风；解表；透疹；止血。
药理作用：1）抗菌和抗炎作用：体外实验证明： 荆芥煎剂对金黄色葡萄球菌和白喉杆菌有较强的抗菌作用。此外，对炭疽杆菌、乙型链球菌、伤寒杆菌、痢疾杆菌、绿脓杆菌和人型结核杆菌等有一定的抑制作用。荆芥煎剂及荆芥与防风混合煎剂均有明显抑制小鼠耳郭肿胀作用，混合煎剂比单煎效果好。荆芥对醋酸引起的炎症有明显的抗炎作用。
2）解热镇痛作用：荆芥煎剂具有解热镇痛作用，用伤寒混合菌苗使家兔发热，给予裂叶荆芥煎剂或乙醇浸剂 2g/kg 灌胃，发现有微弱的解热作用。荆芥的镇痛作用以d-薄荷酮为代表，用d-薄荷酮100mg/kg给小鼠灌胃,能抑制因腹腔注射醋酸引起的扭体反应，其强度与氨基比林相当。
3）止血作用：生品荆芥不能明显缩短出血时间，而荆芥炭则使出血时间缩短72.6%；生品荆芥使凝血时间缩短30%，而荆芥炭缩短77.7%，即荆芥经炒炭后有止血作用。有报告指出，荆芥炭混悬液和荆芥炭挥发油乳剂均有明显的止血作用,且与剂量相关。但荆芥炭水煎剂及提出挥发油后的荆芥炭水煎剂，均未见明显的止血作用。报告者认为，临床上使用荆芥炭治疗各种出血疾病时，应以散剂内服为佳。
续断：补肝肾；强筋骨；调血脉；续折伤；止崩漏。
药理作用：1）抗维生素E缺乏症：经小白鼠和鸡试验，证明续断有抗维生素E缺乏症的作用。
2）止血、镇痛作用：对痈疡有排脓、止血、镇痛、促进组织再生的作用。
槐实：味苦，性寒，归肝、大肠经，功能清热泻火、凉血止血。
药理作用：槐实、槐花为中医习用的凉血止血药，临床多用于吐血、衄血、便血、痔疮出血、尿血、崩漏等属于热证的出血。近代药理研究，槐实、槐花有降压和改善毛细血管脆性的作用。
甘草：益气补中；缓急止痛；润肺止咳；泻火解毒；调和诸药。
具体实施方式
具体实例1：取当归9g、藿香11g、木瓜9g、核桃仁11g、菊花11g、陈皮9g、女贞子11g、芝麻11g、桃仁9g、黄芩9g、山楂9g、荆芥11g、牛蒡子9g、续断9g、槐实11g、甘草8g，浸泡10~15分钟后大火烧至药汁沸腾，然后文火熬制3~4分钟，取出煎熬液内服。
以及，可将以上同等质量的药材粉碎制成外用散剂，配合内服。
半个月为一个疗程，3疗程基本痊愈。
具体实例2：取当归10g、藿香12g、木瓜10g、核桃仁12g、菊花12g、陈皮10g、女贞子12g、芝麻12g、桃仁10g、黄芩10g、山楂10g、荆芥12g、牛蒡子10g、续断10g、槐实12g、甘草9g，浸泡15~20分钟后大火烧至药汁沸腾，然后文火熬制4~5分钟，取出药汁内服。
以及，可将以上同等质量的药材粉碎制成外用散剂，配合内服。
半个月为一个疗程，2疗程基本痊愈。
本发明治疗病例1：刘某某，河南省洛阳人，40岁，腿部烫伤。采用本发明提及的配方，于两个疗程后，症状消失，花费仅千余元。
注意与禁忌：忌食辛辣，海鲜以及其它易发性刺激食物，对麻油过敏者慎用。
触水，对于外伤忌讳的触水。
Claims (2)
1.一种治疗烫伤的中草药配方，其特征是：包括按照重量配比组成为：当归8~12g；藿香10~14g；木瓜8~12g；桃仁8~12g；菊花10~14g；陈皮8~12g；女贞子10~14g；芝麻10~14g；核桃仁10~14g；黄芩8~12g；山楂8~12g；荆芥10~14g；牛蒡子8~12g；续断8~12g；槐实10~14g；甘草7~11g，将按此重量配比组成的药物可制成煎熬液或粉碎成散剂或片剂。
2.根据权利要求1所述的治疗烫伤的在中草药配方，其特征是：最佳重量配比组成为：当归10g；藿香12g；木瓜10g；桃仁10g；菊花12g；陈皮10g；女贞子12g；芝麻12g；核桃仁12g；黄芩10g；山楂10g；荆芥12g；牛蒡子10g；续断10g；槐实12g；甘草9g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310007445.8A CN103505539A (zh) | 2013-01-09 | 2013-01-09 | 一种治疗烫伤的中草药配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310007445.8A CN103505539A (zh) | 2013-01-09 | 2013-01-09 | 一种治疗烫伤的中草药配方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103505539A true CN103505539A (zh) | 2014-01-15 |
Family
ID=49889312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310007445.8A Pending CN103505539A (zh) | 2013-01-09 | 2013-01-09 | 一种治疗烫伤的中草药配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103505539A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105477088A (zh) * | 2016-01-26 | 2016-04-13 | 陕西中医药大学 | 一种治疗皮肤病的纯中药软膏及其用途 |
| CN105641150A (zh) * | 2016-03-31 | 2016-06-08 | 殷桃丽 | 一种烫伤药水的制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1824017A (zh) * | 2005-12-30 | 2006-08-30 | 刘宝昆 | 治疗烧伤或烫伤的中药组合物及其应用 |
-
2013
- 2013-01-09 CN CN201310007445.8A patent/CN103505539A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1824017A (zh) * | 2005-12-30 | 2006-08-30 | 刘宝昆 | 治疗烧伤或烫伤的中药组合物及其应用 |
Non-Patent Citations (2)
| Title |
|---|
| 李寅等: "中医药治疗烧烫伤的研究概况", <<西北药学杂志>> * |
| 王茂先: "中国中医烫伤药的研究概述", <<科技资讯>> * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105477088A (zh) * | 2016-01-26 | 2016-04-13 | 陕西中医药大学 | 一种治疗皮肤病的纯中药软膏及其用途 |
| CN105641150A (zh) * | 2016-03-31 | 2016-06-08 | 殷桃丽 | 一种烫伤药水的制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
| CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
| CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
| CN106491769A (zh) | 治疗外伤的中药复方凝胶剂、制备方法及其应用 | |
| CN102847021B (zh) | 一种治疗溃疡性结肠炎的灌肠剂及其制备方法 | |
| CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
| CN104840695A (zh) | 一种用于治疗仔猪白痢的药物组合物及其制备方法 | |
| CN105056159A (zh) | 一种治疗猪寄生虫病的药物及其制备方法 | |
| CN104721672A (zh) | 一种治疗粘连性肠梗阻的中药制剂及其制备方法 | |
| CN102846824A (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
| CN103505539A (zh) | 一种治疗烫伤的中草药配方 | |
| CN101530516B (zh) | 一种治疗阑尾炎的中药 | |
| CN103610915A (zh) | 一种治疗咽喉肿痛的中药 | |
| CN103341151B (zh) | 用于治疗慢性支气管炎的中药 | |
| CN105456957A (zh) | 一种治疗狐臭的中药组合物 | |
| CN103505593A (zh) | 一种去腐生肌的中草药配方 | |
| CN102451249B (zh) | 一种治疗烧伤、烫伤的药物及其应用 | |
| CN104958757A (zh) | 压疮膏及压疮膏的制备方法 | |
| CN105194029A (zh) | 一种治疗烫伤的中草药配方 | |
| CN103690771B (zh) | 用于治疗羔羊大肠杆菌病的药物及其制备方法 | |
| CN104840838A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
| CN104189608B (zh) | 一种治疗复发性口腔溃疡的中药制剂及制备方法 | |
| CN102309625B (zh) | 一种治疗痔疮疾病的中药组合物及其药液的制备方法 | |
| CN103920042A (zh) | 用于治疗热陷营血型病毒性脑膜炎的药物及其制备方法 | |
| CN103505582B (zh) | 一种治疗烧伤的中草药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140115 |